Emberton M - Search Results

1

Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.

Eldred-Evans D, Neves JB, Simmons LAM, Kanthabalan A, McCartan N, Shah TT, Arya M, Charman SC, Freeman A, Moore CM, Punwani S, Emberton M, Ahmed HU. Eldred-Evans D, et al. Among authors: emberton m. BJU Int. 2020 Mar;125(3):391-398. doi: 10.1111/bju.14953. Epub 2019 Dec 11. BJU Int. 2020. PMID: 31733173

2

Bile duct injury following laparoscopic cholecystectomy.

Cheslyn-Curtis S, Emberton M, Ahmed H, Williamson RC, Habib NA. Cheslyn-Curtis S, et al. Among authors: emberton m. Br J Surg. 1992 Mar;79(3):231-2. doi: 10.1002/bjs.1800790314. Br J Surg. 1992. PMID: 1532527 No abstract available.

3

Towards a minimum dataset in urology.

Thomas K, Emberton M, Mundy AR. Thomas K, et al. Among authors: emberton m. BJU Int. 2000 Nov;86(7):765-72. doi: 10.1046/j.1464-410x.2000.00912.x. BJU Int. 2000. PMID: 11069398

4

A rare tumour in the pelvis presenting with lower urinary symptoms: 'sclerosing epithelioid fibrosarcoma'.

Arya M, Garcia-Montes F, Patel HR, Emberton M, Mundy AR. Arya M, et al. Among authors: emberton m. Eur J Surg Oncol. 2001 Feb;27(1):121-2. doi: 10.1053/ejso.2000.1023. Eur J Surg Oncol. 2001. PMID: 11237504 No abstract available.

5

Couch or crouch? Examining the prostate: a randomized study comparing the knee-elbow and the left-lateral position.

Frank J, Thomas K, Oliver S, Andrews S, Choong S, Taylor R, Emberton M. Frank J, et al. Among authors: emberton m. BJU Int. 2001 Mar;87(4):331-3. doi: 10.1046/j.1464-410x.2001.00066.x. BJU Int. 2001. PMID: 11251525 Clinical Trial.

6

A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?

Irani J, Brown CT, van der Meulen J, Emberton M. Irani J, et al. Among authors: emberton m. BJU Int. 2003 Dec;92(9):937-42. doi: 10.1111/j.1464-410x.2003.04529.x. BJU Int. 2003. PMID: 14632851 Review.

7

Prolonging survival in prostate cancer: chemotherapy will have an important role.

Parker C, Emberton M. Parker C, et al. Among authors: emberton m. BJU Int. 2005 Jul;96(1):2-3. doi: 10.1111/j.1464-410X.2005.05554.x. BJU Int. 2005. PMID: 15963108 No abstract available.

8

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

Moore CM, Hoh IM, Bown SG, Emberton M. Moore CM, et al. Among authors: emberton m. BJU Int. 2005 Oct;96(6):754-8. doi: 10.1111/j.1464-410X.2005.05709.x. BJU Int. 2005. PMID: 16153193 Review. No abstract available.

9

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.

Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M, Bown SG. Moore CM, et al. Among authors: emberton m. Lasers Surg Med. 2006 Jun;38(5):356-63. doi: 10.1002/lsm.20275. Lasers Surg Med. 2006. PMID: 16392142 Clinical Trial.

10

Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia.

Armitage JN, Emberton M. Armitage JN, et al. Among authors: emberton m. BJU Int. 2006 Mar;97(3):439-41. doi: 10.1111/j.1464-410X.2006.06067.x. BJU Int. 2006. PMID: 16469003 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

562 results

Search Page